{
  "predicted_ate": 3.92,
  "predicted_outcome_control_arm": 5.28,
  "metadata": {
    "pipeline_version": "4.0.0",
    "model_type": "lightgbm_with_intervention_conditioning",
    "prediction_date": "2025-10-28T17:55:47.070487",
    "n_training_samples": 24,
    "n_features": 16,
    "cv_rmse": 1.117,
    "cv_std": 0.445,
    "train_rmse": 0.184,
    "train_mae": 0.106
  },
  "prediction_details": {
    "target_rct_id": "NCT01364012",
    "intervention_actual": 9.2,
    "control_actual": 6.5,
    "control_predicted": 5.28,
    "intervention_outcome_conditioning": 9.2,
    "ate_actual": 2.7,
    "ate_predicted": 3.92,
    "prediction_method": "intervention_outcome_conditioning",
    "data_structure": "paired_arms"
  },
  "model_performance": {
    "cross_validation_rmse": 1.117,
    "cross_validation_std": 0.445,
    "training_rmse": 0.184,
    "training_mae": 0.106
  },
  "features_used": [
    "age_median",
    "gender_male_percent",
    "no_smoker_percent",
    "ecog_1",
    "brain_metastase_yes",
    "disease_stage_IV",
    "EGFR_positive_mutation",
    "Chemotherapy",
    "Targeted_Therapy",
    "Immunotherapy",
    "Anti-angiogenic_Other",
    "EGFR_TKI",
    "PD1_PDL1_Inhibitor",
    "intervention_outcome_feature",
    "int_outcome_x_egfr",
    "int_outcome_x_immuno"
  ],
  "config_used": {
    "ftr_list": [
      "age_median",
      "gender_male_percent",
      "no_smoker_percent",
      "ecog_1",
      "brain_metastase_yes",
      "disease_stage_IV",
      "EGFR_positive_mutation",
      "Chemotherapy",
      "Targeted_Therapy",
      "Immunotherapy",
      "Anti-angiogenic_Other",
      "EGFR_TKI",
      "PD1_PDL1_Inhibitor"
    ],
    "target_variable": "PFS_median_months",
    "rct_id_col_name": "NCT_ID",
    "arm_type_col_name": "Arm",
    "target_rct_id": "NCT01364012",
    "data_path": "data/processed_training_data.csv"
  }
}